Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» HER2 Inhibitor
HER2 Inhibitor
OS Therapies’s HER2 therapy prevents lung cancer recurrence in 33% patients
Clinical Trials Arena
Thu, 01/16/25 - 11:06 am
OS Therapies
lung cancer
HER2 Inhibitor
Jazz's HER2 bispecific snags FDA nod, teeing up showdown with AZ and Daiichi's Enhertu
Fierce Pharma
Thu, 11/21/24 - 11:18 am
Jazz Pharma
FDA
HER2 Inhibitor
bispecifics
zanidatamab
Puma drug better than Herceptin in HER2 breast cancers -trial
Reuters
Mon, 04/7/14 - 10:33 am
Herceptin
Puma Biotechnology
HER2 Inhibitor
breast cancer
neratinib
Array BioPharma Licenses Cancer Drug ARRY-543 to ASLAN Pharmaceuticals
Marketwatch
Wed, 07/13/11 - 11:55 am
Array Biopharma
ARRY-543
Aslan
HER2 Inhibitor
cancer
Drug combo helps women with early breast cancer
Yahoo/AP
Sat, 12/11/10 - 12:00 pm
Tykerb
Herceptin
HER2 Inhibitor
breast cancer
Genentech
GSK
ImmunoGen, Inc. Announces Clinical Data for T-DM1 Used in Combination with Pertuzumab for First-Line Treatment of HER2+ Metastatic Breast Cancer
Yahoo/BusinessWire
Sat, 12/11/10 - 11:48 am
Immunogen
T-DM1
Pertuzumab
breast cancer
HER2 Inhibitor
trastuzumab
Array BioPharma Announces Positive Results for HER2 Inhibitor, ARRY-380, in Breast Cancer Patients
Yahoo/BusinessWire
Sat, 10/2/10 - 11:20 am
Array Biopharma
breast cancer
ARRY-380
HER2 Inhibitor